Darvon/Darvocet

CaseyGerry has a strong history in drug litigation including in the case below. We are not currently accepting new clients for this case.  

CaseyGerry drug litigation attorneys worked with clients who were harmed, or who lost loved ones, as a result of using propoxyphene, the active ingredient in the popular prescription painkillers, Darvon and Darvocet. Propoxyphene has been on the market for more than a half-century, and has been considered by many as an antiquated means of pain reduction for some time. In fact, the consumer group Public Citizen began filing petitions with the FDA to ban the drug as early as 1978.

In a study conducted by the U.S. Food and Drug administration (FDA), which ultimately led the manufacturer to voluntarily pull Darvocet from the market, researchers found that even prescribed doses of propoxyphene can lead to cardiotoxicity in patients. Cardiotoxicity creates an irregular heartbeat, known as arrhythmia, which leads to congestive heart failure, heart attack and death. Dr. John Jenkins of the FDA says, “The drug’s effectiveness in reducing pain is no longer enough to outweigh the drug’s serious potential heart risks.”